ESMA FIRDS · Issuer
LEI 52990017AIJPRH3HQH40
52990017AIJPRH3HQH40
1 instruments reported
Primary trading venue: XGAT. Currencies: USD.
Sample instruments
| ISIN | Name | Asset class | Currency | Venue |
|---|---|---|---|---|
| US00773J2024 | Spyre Therapeutics Inc. Registered Shares NEW o.N. | Equity | USD | XGAT |
Issuer pages are generated for entities that appear as issuers of bonds or equity instruments in ESMA FIRDS. Individual instrument classifications reflect ESMA's own CFI-based asset class assignments and may differ from economic substance. All instruments are searchable via the ISIN search.
Look up full entity details for this issuer in the LEI Lookup.
From our insights
- How EU financial regulation actually works: regulations, directives, and technical standards explained
- What are regulatory technical standards and why do they matter more than the regulation itself?
- What does it mean for a regulatory intelligence tool to be source-anchored?
- How to read a CELEX number: understanding EU legal document identifiers
📋 Track EU financial regulation continuously
Forseti monitors EU financial regulation and delivers personalised alerts anchored to verified official sources.
14-day free trial. No credit card required.
Legislation Binding EU law
Proposals Pre-legislative
Guidance Interpretive guidance
Consultations Pre-publication
Case law Binding